OrbiMed’s ObsEva SA Ordinary Shares OBSV Stock Holding History

OrbiMed’s Portfolio OBSV Stock Details OBSV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,303,000	Closed	-$3.23M	–	162
2020 Q3	$3.23M	Sell	1,303,000 -1,302,531	-50%	-$3.72M	0.04%	132
2020 Q2	$15.3M	Hold	2,605,531	–	–	0.22%	85
2020 Q1	$6.28M	Hold	2,605,531	–	–	0.11%	98
2019 Q4	$9.95M	Hold	2,605,531	–	–	0.14%	83
2019 Q3	$21.7M	Hold	2,605,531	–	–	0.41%	59
2019 Q2	$29.5M	Hold	2,605,531	–	–	0.46%	53
2019 Q1	$33.3M	Hold	2,605,531	–	–	0.52%	52
2018 Q4	$33M	Hold	2,605,531	–	–	0.61%	52
2018 Q3	$47M	Hold	2,605,531	–	–	0.57%	56
2018 Q2	$39.4M	Hold	2,605,531	–	–	0.47%	58
2018 Q1	$35.2M	Hold	2,605,531	–	–	0.44%	62
2017 Q4	$25.4M	Hold	2,605,531	–	–	0.32%	72
2017 Q3	$21.2M	Hold	2,605,531	–	–	0.2%	83
2017 Q2	$22.3M	Hold	2,605,531	–	–	0.23%	78
2017 Q1	$27.1M	Buy	+2,605,531	New	+$32M	0.31%	69

Other funds holding OBSV

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

OrbiMed's OBSV Position: Q4 2020 in Review

OrbiMed sold out of ObsEva SA Ordinary Shares (OBSV) in Q4 2020, closing a stake of 1,303,000 shares — an estimated $3.23M sold.

OrbiMed first reported a position in OBSV in Q1 2017 and held it in 15 quarters. The position peaked at $47M in Q3 2018. 41 funds tracked by Wall St. Rank hold OBSV as of Q4 2020.

OrbiMed reported no remaining ObsEva SA Ordinary Shares position as of Q4 2020 after selling out during the quarter.
OrbiMed sold 1,303,000 ObsEva SA Ordinary Shares shares in Q4 2020, an estimated $3.23M.
OrbiMed first reported a position in ObsEva SA Ordinary Shares in Q1 2017 and held it in 15 quarters.
OrbiMed's ObsEva SA Ordinary Shares position peaked at $47M in Q3 2018.
41 funds tracked by Wall St. Rank held ObsEva SA Ordinary Shares as of Q4 2020.

Based on OrbiMed's 13F filing for Q4 2020, filed 16 Feb 2021.